我要投票 冠昊生物GUANHAO在医疗器械行业中的票数:317
· 外 推 电 报 ·
2025-06-21 05:41:56 星期六

【冠昊生物GUANHAO是哪个国家的品牌?】

冠昊生物GUANHAO是什么牌子?「冠昊生物GUANHAO」是 冠昊生物科技股份有限公司 旗下著名品牌。该品牌发源于广东省广州市,由创始人张永明在1999-10-22期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力冠昊生物GUANHAO品牌出海!将品牌入驻外推网,定制冠昊生物GUANHAO品牌推广信息,可以显著提高冠昊生物GUANHAO产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

冠昊生物科技股份有限公司(股票代码:300238,简称冠昊生物)是一家立足再生医学产业,拓展生命健康相关领域,嫁接全球技术资源和成果,面向中国市场进行贯通性产业化的专业化、平台化、生态化产业高科技上市企业。

冠昊生物不断投身于再生医学领域产业化的创新与开发,以生物材料技术和细胞与干细胞技术两大技术体系为支撑,坚持自主创新与国际技术相结合。1999年,建立天然生物材料处理技术平台并实现产业化,目前拥有国内外专利百余项,已上市产品有6种,在研产品数十种,涵盖神经外科、骨科、眼科、烧伤科、整形美容科、妇科等科室。2013年起,公司不断布局细胞与干细胞产业化平台,陆续开展人源组织工程化再生软骨移植治疗技术、免疫细胞储存等技术服务。2014年,冠昊生物与北京大学合作成立“北大冠昊干细胞与再生医学研究院”,立志成为国际化干细胞研究与临床转化平台。

冠昊生物愿与后来者分享创业经验,成立了集合各种资源的、有深度和广度的产业化转化平台——广东冠昊生命健康科技园,搭建专业的生命健康产业领域科技成果产业化转化的平台,吸纳、扶植众多生命健康领域的科技项目和小微企业来园区创业。


英文翻译:Guanhao Biotechnology Co., Ltd. (Stock Code: 300238, referred to as Guanhao biotechnology for short) is a high-tech listed enterprise that bases on the renewable medicine industry, expands the fields related to life and health, grafts the global technical resources and achievements, and carries out the through industrialization in the Chinese market. Guanhao biology has been continuously engaged in the innovation and development of industrialization in the field of regenerative medicine, supported by the two major technical systems of biomaterial technology and cell and stem cell technology, and adheres to the combination of independent innovation and international technology. In 1999, the natural biomaterial processing technology platform was established and industrialized. At present, it has more than 100 patents at home and abroad, 6 products have been listed, and dozens of products are under research, covering neurosurgery, orthopedics, ophthalmology, burn department, plastic and cosmetic department, gynecology and other departments. Since 2013, the company has continuously deployed the industrialization platform of cells and stem cells, and has successively carried out technical services such as human tissue engineering regeneration cartilage transplantation treatment technology, immune cell storage, etc. In 2014, Guanhao biology cooperated with Peking University to establish "Guanhao stem cell and Regenerative Medicine Research Institute of Peking University", aiming to become an international platform for stem cell research and clinical transformation. Guanhao biology is willing to share the entrepreneurial experience with the latecomers, set up Guangdong Guanhao life and health science and Technology Park, a deep and wide industrialization transformation platform integrating various resources, set up a professional platform for the industrialization of scientific and technological achievements in the field of life and health industry, and absorb and support many scientific and technological projects and small and micro enterprises in the field of life and health to start businesses in the park.

本文链接: https://www.waitui.com/brand/930424f51.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美联储理事沃勒:或许最早在七月会议上就可能降息

据报道,美联储理事沃勒表示,或许最早在七月会议上就可能降息。(第一财经)

2小时前

美股大型科技股盘前多数上涨,特斯拉涨超1%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,特斯拉涨超1%,Arm涨0.68%,亚马逊涨0.59%,Meta涨0.39%,苹果涨0.37%,微软涨0.12%;英伟达跌0.02%。

2小时前

热门中概股美股盘前涨跌不一,蔚来涨超1%

36氪获悉,热门中概股美股盘前涨跌不一,截至发稿,蔚来涨超1%,阿里巴巴、网易涨近1%,爱奇艺涨0.59%;京东、拼多多跌近1%,B站跌0.52%,理想汽车跌0.08%,小鹏汽车跌0.05%。

2小时前

朗特智能:控股股东欧阳正良拟询价转让650.9万股,占总股本4.5%

36氪获悉,朗特智能公告,公司控股股东、实际控制人、董事长欧阳正良计划询价转让650.9万股,占公司总股本的4.5%,转让原因为自身资金需求。出让方承诺所持股份权属清晰,不存在限制或禁止转让情形。转让不通过集中竞价交易或大宗交易方式进行,受让方在受让后6个月内不得转让。参与询价转让的投资者需具备相应定价能力和风险承受能力。

2小时前

杰美特:筹划以现金方式购买思腾合力控制权,可能构成重大资产重组

36氪获悉,杰美特公告,公司正在筹划以现金方式购买思腾合力(天津)科技有限公司控制权,交易价格及收购比例待进一步论证和协商。本次交易完成后,思腾合力将成为公司控股子公司。根据初步测算,本次交易可能构成重大资产重组。本次交易拟采用现金方式,不涉及公司发行股份,不构成关联交易,也不会导致上市公司控制权的变更。

2小时前

本页详细列出关于冠昊生物GUANHAO的品牌信息,含品牌所属公司介绍,冠昊生物GUANHAO所处行业的品牌地位及优势。
咨询